(Yicai) Oct.9 -- True Light Capital, a unit of Singapore state investor Temasek, has prepared its first flagship fund of USD3.3 billion to seek investment opportunities in China in fields including new energy and biotech.

Some of the investors include sovereign wealth funds, foundations, financial institutions, and family offices, Singapore-based True Light announced recently.

The flagship fund works alongside Temasek seeking high-quality investment opportunities linked to China. The Light Fund I will focus on key sectors such as life sciences, technology, consumer, industrials, and business services.

True Light is positive about China's long-term fundamentals and outlook and it continues to see attractive opportunities in the four structural trends of digitization, longer lifespans, sustainable living, and the future of consumption, per Yeo Chee Kian, chief executive of the fund.

Some of the innovation areas include the digital transformation of industrial value chains, novel therapeutics and integrated biotech companies, decarbonization technologies such as new energy and battery solutions, as well as new consumer goods and services, Yeo added.

Established in 2021, True Light has around USD3.3 billion in assets under management. Besides its Singapore HQ, it has an office in Shanghai.

Editor: Emmi Laine